Texas Instruments Incorporated

(NASDAQ Global Select)
Bullish +65

Texas Instruments:The Earnings Recovery Has More Room To Run

πŸ“ˆ Analyst rates Texas Instruments (TXN) as a Strong Buy with a 12- to 18-month price target of $332.

πŸ’° Current stock price is $263, implying approximately 26% upside potential from the latest close.

πŸš€ Earnings inflection is driven by accelerating revenue growth and expanding operating profits.

🏭 Recovery is broadening across industrial, data center, and automotive business segments.

πŸ’΅ Forward PEG ratio stands at 1.33x, nearly 70% below the company's five-year average.

βš–οΈ Low valuation relative to history reflects rapid earnings recovery and improved capital efficiency.

⚠️ Main risks include a weaker industrial recovery and slower AI infrastructure spending.

Bullish Signals
  • Analyst rates Texas Instruments as a Strong Buy with a 12- to 18-month price target of $332, implying 26% upside.
  • The company is experiencing an earnings inflection driven by accelerating revenue growth and expanding operating profits.
  • Recovery is broadening across industrial, data center, and automotive segments, indicating diversified strength.
  • Forward PEG ratio of 1.33x is nearly 70% below the five-year average, suggesting undervaluation relative to historical norms.
Risk Factors
  • A weaker industrial recovery poses a risk to overall revenue growth and segment performance.
  • Slower AI infrastructure spending could dampen demand for high-performance computing components.
Full Analysis
Analyst rates Texas Instruments (TXN) as a Strong Buy with a 12- to 18-month price target of $332, implying approximately 26% upside from the current closing price of $263. The investment thesis centers on a clear earnings inflection driven by accelerating revenue growth and expanding operating profits across key segments including industrial, data center, and automotive. Despite trading at premium headline multiples, TXN presents an attractive valuation profile with a forward PEG ratio of 1.33x, which is nearly 70% below its five-year historical average. This discrepancy reflects the company's rapid earnings recovery and improved capital efficiency, suggesting significant room for multiple expansion as financial performance normalizes. The primary risks identified for the stock include a potential slowdown in the industrial sector recovery, decelerating spending on AI infrastructure, and execution challenges surrounding the Silicon Labs acquisition. These factors could impact the trajectory of the anticipated earnings growth and overall market valuation.